We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-6.6%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$24.5B
AUM Growth
-$1.55B
Cap. Flow
+$503M
Cap. Flow %
2.05%
Top 10 Hldgs %
14.23%
Holding
2,483
New
111
Increased
1,136
Reduced
972
Closed
225

Sector Composition

Rank Sector Weight
1 Healthcare 9.12%
2 Technology 8.89%
3 Financials 8.43%
4 Consumer Staples 7.6%
5 Industrials 6.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CY
2226
DELISTED
Cypress Semiconductor
CY
$218K ﹤0.01%
25,566
+4,825
+23% +$50.6K
FMY
2227
First Trust Mortgage Income Fund
FMY
$48.7M
$217K ﹤0.01%
15,184
+268
+2% +$3.85K
MYJ
2228
DELISTED
Blackrock Muni Yield New Jersey Fund, Inc.
MYJ
$217K ﹤0.01%
14,796
+800
+6% +$11.7K
OREX
2229
DELISTED
Orexigen Therapeutics, Inc.
OREX
$217K ﹤0.01%
10,297
+300
+3% +$10.3K
HBM icon
2230
Hudbay
HBM
$12.3B
$214K ﹤0.01%
57,829
+1,681
+3% +$9.67K
HIE
2231
DELISTED
Miller/Howard High Income Equity Fund
HIE
$213K ﹤0.01%
17,659
-6,556
-27% -$98.3K
PDM
2232
Piedmont Realty Trust
PDM
$1.19B
$210K ﹤0.01%
11,724
-10
-0.1% -$179
KST
2233
DELISTED
Deutsche Strategic Income Trust
KST
$210K ﹤0.01%
+20,436
New +$220K
WSCI
2234
DELISTED
WSI Industries Inc
WSCI
$210K ﹤0.01%
41,500
-255
-0.6% -$1.45K
RUTH
2235
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
$209K ﹤0.01%
12,854
-70,803
-85% -$1.16M
TCRT icon
2236
Alaunos Therapeutics
TCRT
$4.86M
$208K ﹤0.01%
154
+18
+13% +$29.7K
BWP
2237
DELISTED
Boardwalk Pipeline Partners
BWP
$207K ﹤0.01%
17,557
-89,350
-84% -$1.22M
FLC
2238
Flaherty & Crumrine Total Return Fund
FLC
$175M
$206K ﹤0.01%
11,050
-15,757
-59% -$301K
LNW
2239
DELISTED
Light & Wonder
LNW
$206K ﹤0.01%
19,692
+1,279
+7% +$16.8K
OIA icon
2240
Invesco Municipal Income Opportunities Trust
OIA
$292M
$206K ﹤0.01%
30,495
UMH
2241
UMH Properties
UMH
$1.36B
$205K ﹤0.01%
22,058
DYAX
2242
DELISTED
DYAX CORPORATION
DYAX
$205K ﹤0.01%
+10,718
New +$256K
WIA
2243
Western Asset Inflation-Linked Income Fund
WIA
$186M
$204K ﹤0.01%
19,362
-20,837
-52% -$228K
CEQP
2244
DELISTED
Crestwood Equity Partners LP
CEQP
$204K ﹤0.01%
8,949
+2,618
+41% +$85.5K
CAA
2245
DELISTED
CalAtlantic Group, Inc.
CAA
$204K ﹤0.01%
5,109
-1,943
-28% -$84.8K
FNSR
2246
DELISTED
Finisar Corp
FNSR
$204K ﹤0.01%
18,369
-11,610
-39% -$182K
CRAY
2247
DELISTED
Cray, Inc.
CRAY
$201K ﹤0.01%
+10,153
New +$236K
AFOP
2248
DELISTED
Alliance Fiber Optic Prod Inc
AFOP
$200K ﹤0.01%
+11,705
New +$220K
ABM icon
2249
ABM Industries
ABM
$2.84B
-241,267
Closed -$7.93M
AIA icon
2250
iShares Asia 50 ETF
AIA
$4.93B
-188,771
Closed -$9.49M

Similar funds

Raymond James & Associates's Q3 2015 Portfolio in Review

As of Q3 2015, Raymond James & Associates held 2,483 positions worth $24.5B, down 5.9% from $26.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Raymond James & Associates's Q3 2015 filing shows 111 new, 1,136 increased, 972 reduced and 225 closed positions. Its largest new stake was Camden Property Trust: 204,814 shares worth $15.1M. The largest sale was KRAFT FOODS GROUP INC COM STK (VA), an estimated $138M.

By sector, the portfolio is most concentrated in Healthcare at 9.1% of assets, down from 9.2% a quarter earlier, followed by Technology and Financials.

  • Raymond James & Associates's largest Q3 2015 buy was Camden Property Trust: 204,814 shares worth $15.1M.
  • Raymond James & Associates added most to ExxonMobil in Q3 2015, an estimated $88.7M increase.
  • Raymond James & Associates's biggest Q3 2015 reduction was TotalEnergies, cutting an estimated $63.3M.
  • Raymond James & Associates fully exited KRAFT FOODS GROUP INC COM STK (VA) in Q3 2015, selling an estimated $138M.
  • Raymond James & Associates's ten largest holdings make up 14% of its $24.5B portfolio in Q3 2015.
  • Raymond James & Associates opened 111 new positions and closed 225 in Q3 2015.
  • Raymond James & Associates's portfolio value fell 5.9% quarter-over-quarter to $24.5B.

Based on Raymond James & Associates's 13F filing for Q3 2015, filed 13 Nov 2015.